At a glance
- Originator Pharmacia Corporation
- Class Cytostatic antibiotics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 15 Sep 1998 Profile reviewed
- 15 Sep 1998 No-Development-Reported for Cancer in Italy (Unknown route)